|Bid||25.31 x 800|
|Ask||25.78 x 1400|
|Day's Range||25.40 - 25.63|
|52 Week Range||21.10 - 26.50|
|Beta (5Y Monthly)||1.43|
|PE Ratio (TTM)||7.20|
|Forward Dividend & Yield||1.81 (7.07%)|
|Ex-Dividend Date||Nov 10, 2021|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for CDR-PBLearn more
Cedar Realty Trust, Inc. (NYSE: CDR) announced today that its Board of Directors has formally approved the payment of a cash dividend of $0.066 per share on the Company's Common Stock, payable on November 22, 2021 to shareholders of record as of the close of business on November 12, 2021.
While stock picking isn't easy, for those willing to persist and learn, it is possible to buy shares in great...
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22. Echo Global Logistics, Inc. (NASDAQ: ECHO) surged 53.8% to $48.16 after the company agreed to be acquired by priva